Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Enlivex Therapeutics Ltd (NASDAQ: ENLV)

 
ENLV Technical Analysis
5
As on 9th Jun 2023 ENLV STOCK Price closed @ 2.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.06 & Strong Sell for SHORT-TERM with Stoploss of 5.53 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ENLVSTOCK Price

Open 2.66 Change Price %
High 2.70 1 Day -0.02 -0.74
Low 2.65 1 Week 0.06 2.29
Close 2.68 1 Month -0.21 -7.27
Volume 9600 1 Year -3.55 -56.98
52 Week High 8.64 | 52 Week Low 2.51
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ENLV
Daily Charts		 ENLV
Intraday Charts		 Whats New @
Bazaartrend		 ENLV
Free Analysis
 
ENLV Important Levels Intraday
RESISTANCE2.78
RESISTANCE2.75
RESISTANCE2.73
RESISTANCE2.71
SUPPORT2.65
SUPPORT2.63
SUPPORT2.61
SUPPORT2.58
 
ENLV Forecast May 2024
Share
4th UP Forecast5.44
3rd UP Forecast4.55
2nd UP Forecast4.01
1st UP Forecast3.46
1st DOWN Forecast1.9
2nd DOWN Forecast1.35
3rd DOWN Forecast0.81
4th DOWN Forecast-0.08
 
ENLV Weekly Forecast
4th UP Forecast4.99
3rd UP Forecast4.25
2nd UP Forecast3.79
1st UP Forecast3.33
1st DOWN Forecast2.03
2nd DOWN Forecast1.57
3rd DOWN Forecast1.11
4th DOWN Forecast0.37
 
ENLV Forecast2024
4th UP Forecast15.03
3rd UP Forecast11.07
2nd UP Forecast8.62
1st UP Forecast6.17
1st DOWN Forecast-0.81
2nd DOWN Forecast-3.26
3rd DOWN Forecast-5.71
4th DOWN Forecast-9.67
 
 
ENLV Other Details
Segment EQ
Market Capital 151794048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ENLV Address
ENLV
 
ENLV Latest News
 
Your Comments and Response on Enlivex Therapeutics Ltd
 
ENLV Business Profile
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. Diseases, such as solid cancers, sepsis, COVID-19, and others reprogram macrophages out of homeostatic state. Its Allocetra has the potential to provide a novel immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents. The company has a research collaboration with Yale Cancer Center for the assessment of Allocetra to enhance the activity of checkpoint inhibitors in solid tumors. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service